These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 18385902)

  • 1. Androgen abuse in sports.
    Handelsman DJ; Heather A
    Asian J Androl; 2008 May; 10(3):403-15. PubMed ID: 18385902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designer androgens in sport: when too much is never enough.
    Handelsman DJ
    Sci STKE; 2004 Jul; 2004(244):pe41. PubMed ID: 15292520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urine testing for designer steroids by liquid chromatography with androgen bioassay detection and electrospray quadrupole time-of-flight mass spectrometry identification.
    Nielen MW; Bovee TF; van Engelen MC; Rutgers P; Hamers AR; van Rhijn JH; Hoogenboom LR
    Anal Chem; 2006 Jan; 78(2):424-31. PubMed ID: 16408923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgenic-anabolic steroids and the Olympic Games.
    Fitch KD
    Asian J Androl; 2008 May; 10(3):384-90. PubMed ID: 18385900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of anabolic androgenic steroid abuse in doping control using mammalian reporter gene bioassays.
    Houtman CJ; Sterk SS; van de Heijning MP; Brouwer A; Stephany RW; van der Burg B; Sonneveld E
    Anal Chim Acta; 2009 Apr; 637(1-2):247-58. PubMed ID: 19286037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgens.
    Iyer R; Handelsman DJ
    Front Horm Res; 2016; 47():82-100. PubMed ID: 27347677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of anabolic steroid abuse using a yeast transactivation system.
    Zierau O; Lehmann S; Vollmer G; Schänzer W; Diel P
    Steroids; 2008 Oct; 73(11):1143-7. PubMed ID: 18550137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of recombinant human LH and hCG on serum and urine LH and androgens in men.
    Handelsman DJ; Goebel C; Idan A; Jimenez M; Trout G; Kazlauskas R
    Clin Endocrinol (Oxf); 2009 Sep; 71(3):417-28. PubMed ID: 19170708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The physiological and pharmacological basis for the ergogenic effects of androgens in elite sports.
    Choong K; Lakshman KM; Bhasin S
    Asian J Androl; 2008 May; 10(3):351-63. PubMed ID: 18385897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen abuse in athletes: detection and consequences.
    Basaria S
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1533-43. PubMed ID: 20139230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nontargeted detection of designer androgens: Underestimated role of in vitro bioassays.
    Lund RA; Cooper ER; Wang H; Ashley Z; Cawley AT; Heather AK
    Drug Test Anal; 2021 May; 13(5):894-902. PubMed ID: 33864649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indirect androgen doping by oestrogen blockade in sports.
    Handelsman DJ
    Br J Pharmacol; 2008 Jun; 154(3):598-605. PubMed ID: 18500381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro androgen bioassays as a detection method for designer androgens.
    Cooper ER; McGrath KC; Heather AK
    Sensors (Basel); 2013 Feb; 13(2):2148-63. PubMed ID: 23389345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous steroid profiling in the athlete biological passport.
    Sottas PE; Saugy M; Saudan C
    Endocrinol Metab Clin North Am; 2010 Mar; 39(1):59-73, viii-ix. PubMed ID: 20122450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of GH abuse in sport: Past, present and future.
    Barroso O; Schamasch P; Rabin O
    Growth Horm IGF Res; 2009 Aug; 19(4):369-74. PubMed ID: 19482501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of androgenic activity of nutraceutical-derived steroids using mammalian and yeast in vitro androgen bioassays.
    Akram ON; Bursill C; Desai R; Heather AK; Kazlauskas R; Handelsman DJ; Lambert G
    Anal Chem; 2011 Mar; 83(6):2065-74. PubMed ID: 21329390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Medication, athletes and doping regulations].
    Hartgens F
    Ned Tijdschr Geneeskd; 2008 Aug; 152(33):1844-8. PubMed ID: 18783164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging drugs: mechanism of action, mass spectrometry and doping control analysis.
    Thevis M; Thomas A; Kohler M; Beuck S; Schänzer W
    J Mass Spectrom; 2009 Apr; 44(4):442-60. PubMed ID: 19373874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testosterone: use, misuse and abuse.
    Handelsman DJ
    Med J Aust; 2006 Oct; 185(8):436-9. PubMed ID: 17137434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the emergence of designer drugs upon sports doping testing.
    Teale P; Scarth J; Hudson S
    Bioanalysis; 2012 Jan; 4(1):71-88. PubMed ID: 22191595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.